The Pharma Data

NOVEMBER 2, 2020

(NASDAQ:ADIL; ADILW) , a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today provided an update on its landmark ONWARD Phase 3 pivotal trial. AUD also represents a dramatically underserved market, as current therapies have limited efficacy and significant side effects.

Trials 52

Trials Genotype Marketing Production 52

Drug Discovery World

OCTOBER 30, 2023

RA: You’ve recently announced a collaboration with the University of Oxford to access genotype data on women with endometriosis. We previously conducted a hypothesis-free study using genotype data from the UK Biobank, which resulted in the first mechanism-based stratification of endometriosis patients.

Genome 72

Genome Genomics Genotype Clinical Trials 72

pharmaphorum

JANUARY 24, 2023

Drug development has long been an issue for the pharma industry, due to the expense and the high failure rate of potential treatments. Ben Hargreaves finds that the vast amount of genetic data that exists today could help provide a faster, more targeted way of developing new drug candidates.

Genetics 96

Genetics Drugs Genome Project Biobanking 96

The Pharma Data

SEPTEMBER 8, 2021

TIB Molbiol excels in ultra-rapid assay development for emerging infectious disease, strongly demonstrated during the COVID-19 pandemic. For example, in 2001 with anthrax and 2003 with SARS-CoV1, TIB Molbiol demonstrated their ability to develop PCR assays for the detection of new pathogens within days. About TIB Molbiol.

Genotype 52

Genotype Reagent Genetics Research 52

Drug Discovery World

NOVEMBER 23, 2023

Narain , PhD, President and CEO of BPGbio asks how a better calibre of biobanks in life sciences can lead to more drugs making it to market. We eagerly await future data read-outs from trials because after all, it is the drug that patients are waiting for, not our fancy algorithms.

Biobanking 59

Biobanking Drugs Medicine Genome 59

XTalks

JANUARY 22, 2021

Taiwan-based health and biotech company MedFluid has developed a rapid automated bacterial identification screening tool that can also tailor antibiotic treatments to an infection. It identifies bacteria using both genotypic and phenotypic assessments within 1.5

Bacteria 52

Bacteria In-Vitro Genotype Marketing 52

pharmaphorum

NOVEMBER 10, 2021

This database should support automatic importation from hospitals, laboratories and surveillance networks and link to genotypic data when available.”. New agents: Development and accessibility. Only six of the 50 anti-bacterials currently in the pipeline meet even one criterion for being innovative.

Medicine 103

Medicine Genome Genomics Genotype 103

pharmaphorum

AUGUST 11, 2022

First, members who opt-in to the program receive a saliva collection kit, which is analysed using newly developed pharmacogenomics technologies. With this promise beginning to be realised, it’s on drug makers to use genomic testing to steer their development process.

Genome 97

Genome Genomics Genetics Drugs 97

Roots Analysis

SEPTEMBER 20, 2023

The market for cannabis-infused products is growing like weed. The legalization of the plant for medical and recreational applications has led to profound growth of this market across the globe. Cannabis testing is also done to identify the plant genotype used to develop the product, providing transparency to the consumers.

Laboratory Information Management System 40

Laboratory Information Management System Production Contamination Containment 40

XTalks

SEPTEMBER 28, 2020

The test was developed by Resolution Bioscience and the company will run test analyses in its labs. The Resolution ctDx Lung assay was developed to offer patients and clinicians with pertinent information that can inform treatment decisions. Related: Liquid Biopsies Help Match Cancer Patients to Phase I Trials.

Gene 105

Gene DNA Life Science Genotype 105

The Pharma Data

MARCH 16, 2022

It’s critical to quickly and accurately identify variants to inform ongoing research – including the ongoing development of therapeutics and vaccines. To support customers performing human genotyping, TIB Molbiol provides custom-made LightSNiP assays for SNP analysis. 2, as well as other mutations, present in the novel B.1.1.529

In-Vitro 52

In-Vitro Genotype Reagent Protein 52

Delveinsight

DECEMBER 16, 2020

As per the WHO, more than 100 types of HPV are found worldwide, out of them at least 13 known HPV genotypes can cause cancer of the cervix. A number of antiretroviral drugs are available in the market today, that can be combined in different ways. However, only about 30% of the infected person develop any symptoms of trichomoniasis.

Bacteria 52

Bacteria Development Genotype Vaccination 52

XTalks

APRIL 24, 2023

This is an increase from the EMA’s approval of two novel ATMPs with orphan designation in 2021 (although the marketing authorization for one of these ATMPs was withdrawn in the European Union in November 2021) and three novel ATMPs with orphan designation in 2020. How Can Study Protocols Be More Effective?

Gene Therapy 95

Gene Therapy Gene Trials Clinical Trials 95

Roots Analysis

AUGUST 31, 2023

Recent advances in DNA sequencing technologies have led to significant developments in healthcare-focused research on precision medicine and diagnostics. Considering the growing popularity and awareness related to personalized nutrition, a number of players may join the market with the aim to make financial profit.

Genome 40

Genome Genomics Genetics Gene 40

Delveinsight

AUGUST 25, 2021

The pharmaceutical industry finds, develops, manufactures, and promotes medicines or pharmaceutical drugs for usage as medications that are administered (or self-administered) to patients in order to cure, vaccinate, or relieve symptoms. billion in research and development. The global healthcare spending in 2020 was USD 8.3

Vaccination 98

Vaccination Vaccine Sales Drugs 98

The Pharma Data

APRIL 7, 2021

Today’s approval is the culmination of a multi-year development program and validates the clinical benefit of this important treatment in metastatic TNBC,” said Merdad Parsey, MD, PhD, Chief Medical Officer, Gilead Sciences. Adverse reactions leading to treatment discontinuation occurred in 5% of patients receiving Trodelvy. The Trodelvy U.S.

HR 52

HR Genotype FDA Approval Genotoxicity 52

The Pharma Data

MARCH 25, 2021

The validation of our EU marketing application is an important step toward addressing the significant unmet medical need for people with metastatic triple-negative breast cancer.”. including final safety information for prescribers) will be assessed as part of ongoing and future Marketing Authorization Applications.

Genotoxicity 52

Genotoxicity Genotype Containment Protein 52

The Pharma Data

NOVEMBER 24, 2020

On November 19, the European Commission granted marketing authorization for Oxlumo for the treatment of PH1 in all age groups, following a positive opinion from the Committee for Medicinal Products for Human Use (CHMP). Visit OXLUMO.com for more information, including full Prescribing Information.

FDA Approval 52

FDA Approval Production RNA Medicine 52

XTalks

DECEMBER 12, 2023

The worldwide market for neurology clinical trials stood at a valuation of $5.24 This is crucial not only for understanding these conditions but also for developing targeted therapeutic strategies. The world of neuroscience trials is rapidly evolving, presenting new challenges and opportunities for researchers and clinicians.

Trials 111

Trials Clinical Trials Clinical Trials Genetics 111